The National Institutes of Health and The Johns Hopkins University School of Medicine present Mitochondrial Biology in Cardiovascular Health and Diseases Conference

OPENING REMARKS:

Dr. Elizabeth Nabel, Director, NHLBI, NIH

EDUCATION OBJECTIVES:

Participants will be able to discuss and explain current advances in the understanding of mitochondrial biology and function at the molecular and biochemical levels. They will also discuss the role of mitochondrial biology in cardiovascular health and disease. Participants will be able to apply these advances to explore the application of novel therapeutics targeting mitochondrial function to modulate cardiac risk factors and treat cardiovascular disease. In addition, researchers will be able to propose collaborative relationships with other health professionals who share an interest in pursuing novel applications in this emerging field.

KEY SCIENTIFIC SESSIONS:

-The Regulatory Control of Mitochondrial Homeostasis                          

-Reactive Oxygen Species Biology, Calcium and the Role of Mitochondria  in Signal Transduction

-Proteomics in Advancing the Understanding of Mitochondrial Biology               

-Imaging of Mitochondrial Function          

-Mitochondrial Dysfunction and Genetic Diseases 

-Mitochondrial Role in Increasing Cardiovascular Risk including Obesity and Type II Diabetes              

-Mitochondrial Function in Cardiovascular Disease                                                               

-Ischemia, Hypertrophy and Heart Failure               

-The Mitochondria as a Therapeutic Target in Cardiovascular Disease